Juggling the impact of disease, treatment, study participation on patients’ lives
MD, PhD Inger Nijhof
Hematologist, St. Antonius Hospital, Department of Internal Medicine, The Netherlands
We all realize myeloma has a major impact on patients’ lives. But also treatments and participating in clinical studies can have a major influence. To what extent is this being discussed with patients?
This e-learning module zooms in on juggling the impact of the disease, treatment and/or participation in clinical studies on the quality of life.
Approximate time: 1 hour
Module 3: Juggling the impact of disease, treatment, study participation on patients’ lives
Accredited for 1 CME point
Scientific Expert Panel
MD, PhD Inger Nijhof
Hematologist,
St. Antonius Hospital,
Department of Internal Medicine,
The Netherlands
MD, PhD Fredrik Schjesvold
Hematologist,
Oslo Myeloma Center,
Department of Hematology,
Norway
MD, PhD Isabelle Vande Broek
Hematologist,
Vitaz, Sint-Niklaas,
Department of Oncology & Hematology,
Belgium
MD Agoston Gyula Szabo
Hematologist,
Righospitalet Copenhagen,
Department of Hematology,
Denmark
MD, PhD Ville Varmavuo
Chief Medical Officer in Education,
Kotka,
Internal Medicine,
Finland
MD, PhD Prof. Xavier Leleu
Hematologist,
Academic Hospital of Poitiers,
France
MD Valdas Peceliunas
Hematologist,
Vilnius University Hospital Santaros Klinikos,
Department of Hematology,
Lithuania
Accreditation
Accreditation for this e-learning has been granted for 1 point per module by:
European Accreditation Council for Continuing Medical Education (EACCME) & Nederlandse Internisten Vereniging (NIV)
Obtain CME points
To obtain CME points, you must answer at least 70% of the questions in the final test correctly. If you have a lower score, you can retake the final test twice more. You can pause the e-learning and then resume where you paused.
Clinical cases
Throughout the e-learning challenging clinical cases from daily practice are being presented by the International Expert Panel.
